231 related articles for article (PubMed ID: 6092464)
1. A human hybrid myeloma for production of human monoclonal antibodies.
Kozbor D; Tripputi P; Roder JC; Croce CM
J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464
[TBL] [Abstract][Full Text] [Related]
2. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
3. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
5. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
6. Determination of the optimal human cell lines for development of human hybridomas.
Abrams PG; Knost JA; Clarke G; Wilburn S; Oldham RK; Foon KA
J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
[TBL] [Abstract][Full Text] [Related]
7. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
Gustafsson B; Jondal M; Sundqvist VA
Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
[TBL] [Abstract][Full Text] [Related]
8. Production of large quantities of human immunoglobulin in the ascites of athymic mice: implications for the development of anti-human idiotype monoclonal antibodies.
Abrams PG; Ochs JJ; Giardina SL; Morgan AC; Wilburn SB; Wilt AR; Oldham RK; Foon KA
J Immunol; 1984 Apr; 132(4):1611-3. PubMed ID: 6699400
[TBL] [Abstract][Full Text] [Related]
9. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
[TBL] [Abstract][Full Text] [Related]
10. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal antibodies produced by human-human hybridomas].
Chida J
Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
[TBL] [Abstract][Full Text] [Related]
12. A human hybrid hybridoma.
Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
[TBL] [Abstract][Full Text] [Related]
13. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
[TBL] [Abstract][Full Text] [Related]
14. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
[TBL] [Abstract][Full Text] [Related]
15. A human myeloma cell line suitable for the generation of human monoclonal antibodies.
Karpas A; Dremucheva A; Czepulkowski BH
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1799-804. PubMed ID: 11172031
[TBL] [Abstract][Full Text] [Related]
16. Isolation of human monoclonal antibodies binding to B fragment of diphtheria toxin.
Gupta KC; Agha R; Santos E; Brodeur BR
Hum Antibodies Hybridomas; 1992 Jan; 3(1):25-31. PubMed ID: 1576320
[TBL] [Abstract][Full Text] [Related]
17. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines.
Cole SP; Campling BG; Louwman IH; Kozbor D; Roder JC
Cancer Res; 1984 Jul; 44(7):2750-3. PubMed ID: 6327024
[TBL] [Abstract][Full Text] [Related]
18. [Optimal production of murine monoclonal antibodies in ascites of syngeneic mice by a single whole body irradiation].
Witt S; Ziegler B; Klöting I; Nadrowitz R; Schmidt W; Ziegler M
Allerg Immunol (Leipz); 1987; 33(4):259-64. PubMed ID: 2964179
[TBL] [Abstract][Full Text] [Related]
19. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
Tokunaga T; Chiba J; Ohnishi K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2198-204. PubMed ID: 3038035
[TBL] [Abstract][Full Text] [Related]
20. Influence of avidity and idiotope recognition on the modulation of surface immunoglobulin on malignant human B cells by rat monoclonal anti-idiotype antibodies.
Campbell M; Bieber M; Levy R; Teng NN
J Immunol; 1986 Apr; 136(8):2983-8. PubMed ID: 3485677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
